{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-003192","form_type":"8-K","ticker":"NEOG","cik":"0000711377","company_name":"NEOGEN CORP","filed_at":"2024-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.718906+00:00","generated_at":"2026-06-07T01:43:23.770258+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Neogen Q2 FY2024 revenue $229.6M, net loss $(0.02)/sh; lowers full-year outlook","bullets":["Revenue $229.6M, roughly flat YoY; Food Safety +1.9%, Animal Safety -5.0%.","Net loss $3.5M ($(0.02)/sh) vs prior $41.8M loss; Adjusted Net Income $24.9M ($0.11) vs $31.4M.","Adjusted EBITDA $55.1M (24.0% margin) vs $64.1M (27.8%) a year ago.","FY2024 guidance lowered: revenue $935M-$955M, Adj. EBITDA $230M-$240M; slower end-market recovery.","Animal Safety hurt by distributor destocking and Genomics shift; Food Safety core growth 0.7%."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-003192","json":"https://secwatch.observer/filing/0000950170-24-003192.json","markdown":"https://secwatch.observer/filing/0000950170-24-003192.md","text":"https://secwatch.observer/filing/0000950170-24-003192.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/711377/000095017024003192/0000950170-24-003192-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/711377/000095017024003192/neog-20240109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:43:23.770258+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a677a5420f3a954efc50c13a9a405a4263e642fd","claim":"NEOGEN CORP reported second quarter ended November 30, 2023 results: revenue Revenue of $229.6 million., net income Net loss of $3.5 million; $(0.02) per diluted share.. Guidance reaffirmed.","evidence_excerpt":"regardless of any general incorporation language in the filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Neogen Announces Second-Quarter 2024 Results • Revenue of $229.6 million. • Net loss of $3.5 million; $(0.02) per diluted share. • Adjusted Net Income of $24.9 million; $0.11 per diluted share. • Adjusted EBITDA of $55.1 million, at a margin of 24.0%.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/711377/000095017024003192/0000950170-24-003192-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended November 30, 2023"},{"label":"Revenue","value":"Revenue of $229.6 million."},{"label":"Net income","value":"Net loss of $3.5 million; $(0.02) per diluted share."},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}